Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

TrueBlue Sees Q4 Sales $399.000M-$424.000M vs $410.873M Est

Author: Benzinga Newsdesk | November 03, 2025 04:26pm
TrueBlue (NYSE:TBI) sees Q4 sales of $399.000 million-$424.000 million vs $410.873 million analyst estimate.

Posted In: TBI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist